Mandate

vinge advises on sale of Grolls

May 06, 2016

Vinge is advising Litorina and other owners in connection with the sale of Björnkläder Intressenter AB (Grolls), the leading supplier of workwear and personal protection equipment in the Nordic region.

The purchaser is Swedol, a leading supplier of tools, personal protection equipment and accessories for professional users in Sweden and Norway. The transaction is subject to the approval of the Swedish Competition Authority.

Vinge’s team consisted of partners Jonas Johansson and Johan Winnerblad together with, among others, associates Gustav Tengblad, Andrea Ahlgren, Helena Håkansson and Eleonor Kjellén as well as project assistants Josefin Backlund, Christoffer Widström and Anna Hellohf.

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024